China Resources Boya Bio-pharmaceutical Issues Sharp 2025 Profit Warning
China Resources Boya Bio-pharmaceutical, a key player in biopharmaceuticals, has released a stark profit warning for 2025, forecasting net profit attributable to shareholders at RMB105 million to









